<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet type="text/xsl" href="/static/oaitohtml.xsl"?>

<!--
<?xml-stylesheet type="text/xsl" href="/oaitohtml.xsl"?>
-->

<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <responseDate>2026-10-12T06:48:24Z</responseDate>
    <request verb="GetRecord" metadataPrefix="oai_dc" identifier="10.11922/sciencedb.01520" >https://www.scidb.cn/oai</request>
<GetRecord>
    <record>
    <header >
    <identifier>10.11922/sciencedb.01520</identifier>
    <datestamp>2022-02-15T10:39:21Z</datestamp>
</header>
    <metadata>
        
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:date>2022-02-15</dc:date>
  <dc:title>ZSS alkaloids</dc:title>
  <dc:identifier>doi:10.11922/sciencedb.01520</dc:identifier>
  <dc:language>en</dc:language>
  <dc:description>This study aimed to investigate the antidepressant mechanism of the alkaloid fraction of Ziziphi Spinosae Semen&amp;nbsp;(AZSS)&amp;nbsp;on depressed mice using network pharmacology and pharmacodynamics. Data on the active ingredients and targets were retrieved from&amp;nbsp;TCMSP Platform, and the therapeutic targets&amp;nbsp;for depression were retrieved using GeneCards&amp;nbsp;database;&amp;nbsp;Venn diagrams determined&amp;nbsp;the intersecting targets. STRING platform constructed&amp;nbsp;an AZSS-antidepressant network. With Cluster Profiler R, the common targets were analyzed using&amp;nbsp;GO&amp;nbsp;analysis. The nitric oxide (NO)&amp;nbsp;content in the brain was determined by fluorescence spectrophotometry,&amp;nbsp;and the molecular docking of AZSS-NO synthase&amp;nbsp;(NOS) was performed by&amp;nbsp;Autodock. Nine&amp;nbsp;active components and nine&amp;nbsp;intersecting&amp;nbsp;targets were&amp;nbsp;analyzed, exerting 57 molecular functions. NOS binding was found to be one of the main biological processes targeted by AZSS, and AZSS containing the&amp;nbsp;SLC6A4&amp;nbsp;segment, that is, (S)-coclaurine, sanjoinine E, dl-nuciferine, and n-methylasimilobine, exhibited this property. NO levels were lower in the venlafaxine and AZSS groups than in the model group (P&amp;lt;0.01). The four SLC6A4-containing AZSS components had high molecular docking energy with NOS. The results suggest that the SLC6A4-containing AZSS components exert antidepressant effects by binding to NOS and interfering with the elevation of NO levels in brain tissue of depressed mice.</dc:description>
  <dc:subject>Ziziphi Spinosae Semen; alkaloids site; Network Pharmacology; Nitric oxide</dc:subject>
  <dc:creator>LILU</dc:creator>
  <dc:creator>Wang Lu</dc:creator>
  <dc:creator>Sun Yan</dc:creator>
  <dc:creator>Qiao Wei</dc:creator>
  <dc:rights>PUBLIC</dc:rights>
  <dc:rights>https://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
  <dc:type>dataset</dc:type>
  <dc:publisher>Science Data Bank</dc:publisher>
</oai_dc:dc>

    </metadata>
</record>
</GetRecord>
</OAI-PMH>